147 related articles for article (PubMed ID: 1786470)
1. Current approaches to the preparation of plasma fractions.
Vandersande J
Biotechnology; 1991; 19():165-76. PubMed ID: 1786470
[No Abstract] [Full Text] [Related]
2. Factors determining quality of plasma.
Myllylä G
Vox Sang; 1998; 74 Suppl 2():507-11. PubMed ID: 9704491
[No Abstract] [Full Text] [Related]
3. New trends in plasma fractionation.
Steinbuch M
Haematologia (Budap); 1983; 16(1-4):39-51. PubMed ID: 6207083
[No Abstract] [Full Text] [Related]
4. Plasma fractionation in England and Wales.
Vallet L
Vox Sang; 1972; 23(1):58-60. PubMed ID: 4628157
[No Abstract] [Full Text] [Related]
5. The development of plasma derivatives in Australia.
Schiff P
Vox Sang; 1972; 23(1):38-43. PubMed ID: 4628156
[No Abstract] [Full Text] [Related]
6. [Therapeutic use of hemoderivatives].
Yurrebaso Eguilior N; Mota Villaplana FM; Montoro Ronsano JB
Sangre (Barc); 1997 Oct; 42(5):423-7. PubMed ID: 9424747
[No Abstract] [Full Text] [Related]
7. Advances in plasmatic fractions used in blood transfusion.
Hollan SR
Rev Fr Transfus Immunohematol; 1979 Feb; 22(1):17-33. PubMed ID: 386471
[TBL] [Abstract][Full Text] [Related]
8. New trends in plasma fractionation and plasma products.
Burnouf T
Vox Sang; 1994; 67 Suppl 3():251-3. PubMed ID: 7975504
[No Abstract] [Full Text] [Related]
9. [Plasmapheresis as a method of production of blood fractions].
Lautner A
Bibl Haematol; 1969; 32():212-6. PubMed ID: 5822799
[No Abstract] [Full Text] [Related]
10. Notes on the production of plasma derivatives in France.
Steinbuch M
Vox Sang; 1972; 23(1):56-7. PubMed ID: 4117049
[No Abstract] [Full Text] [Related]
11. Notes on plasma derivative production in the Federal Republic of Germany.
Schwick HG
Vox Sang; 1972; 23(1):44. PubMed ID: 5081013
[No Abstract] [Full Text] [Related]
12. Clearance of dengue virus in the plasma-derived therapeutic proteins.
Xie YW; Chan PK; Szeto CK; Kwok SY; Chu IM; Chu SS; Cheung JL; Wong SW; Ali MB; Wong BL
Transfusion; 2008 Jul; 48(7):1342-7. PubMed ID: 18315529
[TBL] [Abstract][Full Text] [Related]
13. What is blood and what is not? Caring for the Jehovah's Witness patient undergoing cardiac surgery.
Sniecinski R; Levy JH
Anesth Analg; 2007 Apr; 104(4):753-4. PubMed ID: 17377074
[No Abstract] [Full Text] [Related]
14. [Plasmapheresis as a method for obtaining blood derivatives in traumatology].
Lautner A
Wien Med Wochenschr; 1968 May; 118(20):469-71. PubMed ID: 5702498
[No Abstract] [Full Text] [Related]
15. Differential interaction of clotting factors II, VII, IX and X with sephadex and dextran blue.
Swart AC; Kop-Klaassen BH; Hemker HC
Haemostasis; 1972-1973; 1(5):237-52. PubMed ID: 4670119
[No Abstract] [Full Text] [Related]
16. The use of chromatography to manufacture purer and safer plasma products.
Johnston A; Adcock W
Biotechnol Genet Eng Rev; 2000; 17():37-70. PubMed ID: 11255674
[No Abstract] [Full Text] [Related]
17. Proteomic analysis of human plasma: failure of centrifugal ultrafiltration to remove albumin and other high molecular weight proteins.
Georgiou HM; Rice GE; Baker MS
Proteomics; 2001 Dec; 1(12):1503-6. PubMed ID: 11747208
[TBL] [Abstract][Full Text] [Related]
18. The current status of blood fractionation in the United States.
Sgouris JT
Vox Sang; 1972; 23(1):45-55. PubMed ID: 5081014
[No Abstract] [Full Text] [Related]
19. Chromatographic methods of fractionation.
Friesen AD
Dev Biol Stand; 1987; 67():3-13. PubMed ID: 3609484
[TBL] [Abstract][Full Text] [Related]
20. [Current status and trends in blood biologicals].
Wang Z; Zhao X; Lv M; Zhang J
Sheng Wu Gong Cheng Xue Bao; 2011 May; 27(5):730-46. PubMed ID: 21845840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
